How do you approach a patient with Stage I node negative ER+ invasive ductal carcinoma s/p lumpectomy who has an intermediate Oncotype?

Intermdiate scores always require a long discussion with the patient - this is definitely a case with no one answer. The potential benefit of ANY chemotherapy is quite small. Some patients may accept chemo for that small benefit, others easily defer. I haven't used AC alone in many years. When I do ...

I agree with Kathy's comments. Parenthetically I never order an Oncotype or other genomic test without discussing what we will do with the results with the patient. Decision-making regarding an intermediate score in a stage I patient usually involves the other characteristics (age, comorbidity, pers...